Clinical trial
A One-year Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy
NCT00401076 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A One-year Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy
- Lead sponsor
- Abbott
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- September 30, 2010
- Enrollment
- 80 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic exocrine insufficiency, chronic pancreatitis, pancreatectomy